Verano’s active operations span 13 states, comprised of 162 dispensaries operating under the Zen Leaf™ and MÜV™ retail banners, and 14 cultivation and processing facilities with more than 1.1 million square feet of cultivation capacity
CHICAGO, April 23, 2026 — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, celebrates today’s announcement that cannabis will be rescheduled from Schedule I to Schedule III in the Controlled Substances Act.
Quote from Verano Founder and Chief Executive Officer George Archos:
“We’re thankful for the leadership, commitment and coordinated efforts of President Trump and Attorney General Blanche to reschedule cannabis to Schedule III, which will provide countless health and wellness benefits for Americans nationwide.
Completing the historic rescheduling of cannabis to Schedule III promises to unlock the full medical, research and commercial potential of this miracle plant and support the growth and normalization of America’s next great industry in the United States.”
About Verano
Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano provides a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf™ and MÜV™ dispensary banners, and produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Savvy™, (the) Essence™, Swift Lifts™, HYPHEN™, Encore™, BITS™, Avexia™, MÜV™, CTPharma™, and Verano™. Verano’s active operations span 13 U.S. states, comprised of 14 production facilities with over 1.1 million square feet of cultivation capacity. Learn more at Verano.com.
